» Articles » PMID: 22002412

Factors Predictive of Recurrence and Mortality After Surgical Repair of Enterocutaneous Fistula

Overview
Specialty Gastroenterology
Date 2011 Oct 18
PMID 22002412
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Many enterocutaneous fistulas (ECF) require operative treatment. Despite recent advances, rates of recurrence have not changed substantially. This study aims to determine factors associated with recurrence and mortality in patients submitted to surgical repair of ECF. Consecutive patients submitted to surgical repair of ECF during a 5-year period were studied. Several patient, disease, and operative variables were assessed as factors related to recurrence and mortality through univariate and multivariate analysis. There were 35 male and 36 female patients. Median age was 52 years (range, 17-81). ECF recurred in 22 patients (31%), 18 of them (82%) eventually closed with medical and/or surgical treatment. Univariate analyses disclosed noncolonic ECF origin (p = 0.04), high output (p = 0.001), and nonresective surgical options (p = 0.02) as risk factors for recurrence; the latter two remained significant after multivariate analyses. A total of 14 patients died (20%). Univariate analyses revealed risk factors for mortality at diagnosis or referral including malnutrition (p = 0.03), sepsis (p = 0.004), fluid and electrolyte imbalance (p = 0.001), and serum albumin <3 g/dl (p = 0.02). Other significant variables were interval from last abdominal operation to ECF operative treatment ≤20 weeks (p = 0.03), preoperative serum albumin <3 g/dl (p = 0.001), and age ≥55 years (p = 0.03); the latter two remained significant after multivariate analyses. Interestingly, recurrence after surgical treatment was not associated with mortality (p = 0.75). Among several studied variables, recurrence was only independently associated with high output and type of surgical treatment (operations not involving resection of ECF). Interestingly, once ECF recurred its management was as successful as non-recurrent fistulas in our series. Mortality was associated to previously-reported bad prognostic factors at diagnosis or referral.

Citing Articles

Surgical approach for a refractory enterocutaneous fistula by combining laparoscopic surgery and a planned open conversion: a case report.

Hasegawa M, Ogino T, Sekido Y, Takeda M, Hata T, Hamabe A Surg Case Rep. 2024; 10(1):186.

PMID: 39138697 PMC: 11322469. DOI: 10.1186/s40792-024-01987-7.


Injectable Nanoengineered Adhesive Hydrogel for Treating Enterocutaneous Fistulas.

de Barros N, Gangrade A, Elsebahy A, Chen R, Zehtabi F, Ermis M Acta Biomater. 2024; 173:231-246.

PMID: 38465268 PMC: 10919932. DOI: 10.1016/j.actbio.2023.10.026.


Adipose tissue-derived stem cells as a therapeutic strategy for enterocutaneous fistula: an experimental model study.

Pagotto V, Camargo C, Caceres P, Altran S, Gemperli R Acta Cir Bras. 2023; 38:e384523.

PMID: 37851787 PMC: 10578092. DOI: 10.1590/acb384523.


Treatment of enterocutaneous fistula: a systematic review and meta-analysis.

Gefen R, Garoufalia Z, Zhou P, Watson K, Emile S, Wexner S Tech Coloproctol. 2022; 26(11):863-874.

PMID: 35915291 DOI: 10.1007/s10151-022-02656-3.


Postoperative enterocutaneous fistulas: Management outcomes in 23 consecutive patients.

Noori I Ann Med Surg (Lond). 2021; 66:102413.

PMID: 34040778 PMC: 8144527. DOI: 10.1016/j.amsu.2021.102413.


References
1.
McIntyre P, Ritchie J, HAWLEY P, Bartram C, Lennard-Jones J . Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg. 1984; 71(4):293-6. DOI: 10.1002/bjs.1800710416. View

2.
Sarfeh I, Jakowatz J . Surgical treatment of enteric 'bud' fistulas in contaminated wounds. A riskless extraperitoneal method using split-thickness skin grafts. Arch Surg. 1992; 127(9):1027-30; discussion 1030-1. DOI: 10.1001/archsurg.1992.01420090031005. View

3.
Jamshidi R, Schecter W . Biological dressings for the management of enteric fistulas in the open abdomen: a preliminary report. Arch Surg. 2007; 142(8):793-6. DOI: 10.1001/archsurg.142.8.793. View

4.
Dudrick S, Maharaj A, McKelvey A . Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg. 1999; 23(6):570-6. DOI: 10.1007/pl00012349. View

5.
Soeters P, Ebeid A, Fischer J . Review of 404 patients with gastrointestinal fistulas. Impact of parenteral nutrition. Ann Surg. 1979; 190(2):189-202. PMC: 1344487. DOI: 10.1097/00000658-197908000-00012. View